Table 1.
Relationship of the presence or absence of CD19+ cells coexpressing CD10 and/or CD34 on day 19 with presenting clinicobiologic features of children with ALL
|
CD19+ cells coexpressing CD10 and/or CD34 on day 19
|
||||
|---|---|---|---|---|
| Presenting feature | Patients studied | Absent | Present | P* |
| Age, y | .962 | |||
| Younger than 1 | 6 | 3 | 3 | |
| 1 to 9 | 288 | 128 | 160 | |
| 10 or older | 86 | 38 | 48 | |
| Race | .916 | |||
| White | 301 | 135 | 166 | |
| Black | 48 | 20 | 28 | |
| Other | 31 | 14 | 17 | |
| Sex | .164 | |||
| Male | 204 | 84 | 120 | |
| Female | 176 | 85 | 91 | |
| WBC, × 109/L | .246 | |||
| Less than 50 | 300 | 138 | 162 | |
| 50 or more | 80 | 31 | 49 | |
| BCR-ABL† | .001 | |||
| Absent | 366 | 169 | 197 | |
| Present | 13 | 0 | 13 | |
| TEL-AML 1† | < .001 | |||
| Absent | 273 | 110 | 163 | |
| Present | 83 | 51 | 32 | |
| MLL-AF4† | .834 | |||
| Absent | 373 | 167 | 206 | |
| Present | 4 | 2 | 2 | |
| DNA index | .083 | |||
| 1.16 or more | 111 | 57 | 54 | |
| Other | 269 | 112 | 157 | |
| NCI risk | .791 | |||
| Standard | 227 | 102 | 125 | |
| High | 147 | 64 | 83 | |
| Not applicable | 6 | 3 | 3 | |
Calculated by Pearson chi-square test.
Data not available for all patients.